Introduction
Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood. Like other tumors, ALL is thought to result from the accumulation of genomic abnormalities that affect the normal control of cellular growth. It is widely accepted that tumor initiation and/or progression is the result of oncogene activation and tumor suppressor gene (TSG) inactivation. 1 Following cytogenetic studies, numerous recurrent chromosomal aberrations have been identified in childhood ALL 2 and in many cases, the translocation breakpoints have been characterized, showing that these translocations juxtapose genes that are normally separate in the genome, thereby activating proto-oncogenes or creating novel chimeric genes. 3 Until recently, less attention has been given to the significance of recurring cytogenetic deletions that suggest the role of tumor suppressor gene inactivation in leukemogenesis. 4 The stepwise inactivation of both alleles of a TSG that may occur through a variety of different mechanisms 5 can often be suspected by observation of a loss of heterozygosity (LOH) for polymorphic markers at a specific chromosomal site.
Several ALL studies have pointed out the sensitivity of this approach for detecting small deletions and showed that the frequencies of deletional events in 9p21 and 12p13 chromosomal regions are underestimated by cytogenetic studies. [6] [7] [8] Correspondence: B Grandchamp, INSERM U409, Faculté de Méde-cine Bichat, BP 416, 75870 Paris cedex 18, France; Fax: 01 42 26 46 24 Received 15 January 1998; accepted 17 March 1998 Furthermore, the LOH approach has permitted delineation of a 6 cM interval in the 6q21-22 chromosomal band that is deleted in 7% of childhood ALL. 9 Genome-wide LOH scan or allelotype analysis of tumor DNA was first performed for colorectal cancer. 10 Since then, this approach has been used to study many different tumor types and has successfully contributed to the isolation of several tumor suppressor genes. 11, 12 In childhood ALL, the results of two allelotypes have been reported, the most frequently affected regions being the 9p and 12p chromosomal arms in agreement with cytogenetic and molecular studies. These allelotype analyses used only one or two polymorphic microsatellite markers per chromosomal arm, a number too small to efficiently detect small interstitial deletions. 13, 14 The recent development of semi-automated techniques using fluorescentlabeled primers for the genotyping of microsatellites prompted us to extend our previous work and to perform a more complete allelotyping in 63 patients with B-lineage ALL, using 247 microsatellites, evenly distributed on all chromosomes.
Patients and methods

Patients
Sixty-three patients with B-lineage ALL were included in this study. They were not selected according to any risk factor or cytogenetic data. ALL was classified on the basis of the lymphoid morphologic appearance of blasts and their immunophenotype as assessed by flow cytometry. The diagnosis of B-precursor ALL was based on the expression of B cell-associated antigens (CD19
) and the lack of surface membrane immunoglobulins. Karyotype studies were systematically performed at presentation.
Informed consent was obtained from the patients, their parents, or both, as appropriate.
Sample collection and preparation of mononuclear cell lysates Bone marrow was collected in EDTA before induction therapy and during clinical remission according to the European Organisation for Research and Treatment of Cancer (EORTC) 58 881 follow-up protocol. At the time of diagnosis, all bone marrow samples contained more than 70% of blasts. Mononuclear cells were separated by gradient centrifugation over Ficoll (Lymphoprep; Pharmacia, Uppsala, Sweden), washed in 0.9% NaCl, counted, and aliquots of cells were stored at −80°C. Erythrocytes were lysed by resuspending the cells in a solution containing 10 mmol TRIS-HCl (pH 7.5), 1% Triton-100 (Sigma, St Louis, MO, USA), 5 mmol MgCl 2 and 0.32 mmol saccharose. After centrifugation, mononuclear cells were lysed in a buffer containing 0.45% Tween 20 (Difco, Detroit, MI, USA), 1.45% Nonidet P40 (Sigma), 2.5 mmol MgCl 2 and 10 mmol TRIS-HCl (pH 7.5) and incubated for 2 h at 60°C in the presence of 1 mg/ml proteinase K. Volumes were adjusted to obtain 10 ng of DNA per l of lysate. After a 10-min incubation at 95°C, the lysates were stored at −20°C until analysis.
Genotyping studies
Two hundred and forty-seven simple tandem repeat polymorphic markers were used. All of them were repeats of CA dinucleotides identified at the Genethon, 15 evenly distributed over the entire genome. The complete list of markers is available on request. PCR and microsatellite analysis were performed at Genethon using fluorescent-labeled primers and an automated DNA laser sequencer (Applied Biosystems, Foster City, CA, USA). PCR was performed in a total volume of 15 l containing 30 ng of genomic DNA, 5 pmol of each primer, 125 M dNTPs, 1.5 mmol MgCl 2 , 500 mmol KCl, 100 mmol Tris-HCl (pH 8.3) and 1 U of Taq polymerase. Taq polymerase was added after a denaturation step of 5 min at 96°C. Samples were then processed through two cycles of denaturation (94°C for 40 s), and annealing (70°C for 30 s), two cycles of denaturation (94°C for 40 s), and annealing (65°C for 30 s), two cycles of denaturation (94°C for 40 s), and annealing (60°C for 30 s), 27 cycles of denaturation (94°C for 40 s), and annealing (57°C for 30 s), followed by an elongation step (2 min at 72°C). The PCR products obtained from the blasts were compared with those obtained from normal cells of the same patient obtained during remission.
Results
We studied samples from 63 B-lineage childhood ALLs for LOH with a panel of highly informative microsatellite markers evenly distributed over the genome. The allelic status of the blast cells was assessed by comparing the PCR products amplified from diagnostic samples to those amplified from remission samples from the same patients. The status of the markers was effectively determined in an average of 40 patients per locus. Absence of interpretable information resulted either from homozygosity of the marker in normal DNA or to technical failure. A total of 9880 informative genotypes was analyzed and results indicating LOH were confirmed by a second independent PCR before being interpreted. A total of 239 (2.4%) LOH were detected. From 247 markers, 119 (48%) showed no LOH, 76 (30%) showed LOH in a single patient and 52 (21%) showed LOH in at least two patients. The number of informative markers for each patient is indicated in Table 1 .
Markers showing LOH were mapped to a total of 32 independent regions distributed over most chromosomal arms except 2q, 3p, 3q, 17p and 18p. The cumulative results of LOH observed on different chromosomes are illustrated in Figure 1 .
Only six regions displayed LOH for four or more patients ( Table 2) . Three of these regions 9p, 12p and 6q have been previously identified as the targets of recurring deletions in ALL. 4 Not surprisingly, the most frequent LOH are detected by markers mapped to chromosomal arms 9p and 12p in proximity to the frequently deleted MTS1 and ETV6 genes, respectively. 6, 16 Detailed results of LOH results are given for the three additional regions identified in the present study: 5p, 10p, and 20q ( Figure 2 ). In nine patients, all markers on one or several chromosomes showed LOH (Table 1) in the absence of corresponding monosomies detected by cytogenetics (patients 5, 6, 18, 30, 43, 47, 49, 59, 63). It seems likely that at least in some of these cases, LOH reflects an acquired parental isodisomy rather than a chromosomal loss. Interestingly, six out of these nine patients had a hyperdiploid karyotype. Two children with LOH involving all markers on the same chromosome (patients 1 and 59) had a normal karyotype, but patient 59 had a DNA index of 1.19 (data not shown), suggesting that at least for this patient a hyperploid clone was present but that cytogenetics failed to detect it.
A majority of patients (64%) had at least one LOH, while 36% had no LOH. As proposed by Vogelstein et al, 10 the fractional allelic loss (FAL) index was computed as the fraction of evaluable nonacrocentric chromosomal arms demonstrating LOH for at least one marker. Since this index does not take into account the size of the chromosomal region showing LOH, we also calculated a hemizygosity index 17 as the ratio of the number of loci that demonstrated LOH to the number of informative loci tested. The mean FAL and hemizygosity index were 0.03 (range 0 to 0.23) and 0.024 (range 0 to 0.18), respectively. The median number of independent chromosomal regions displaying LOH was one per patient; the observed distribution of this parameter among the series of patients that we studied is shown in Figure 3 . The apparently bimodal distribution suggests that the studied population may be heterogenous with a minor subgroup of patients having a higher number of regions with LOH per patient than the majority of the patients.
The possible association between the FAL index and LOH at specific chromosomal arms was tested by the Mann-Whitney U-test for the most commonly deleted regions 9p and 12p. For this purpose, LOH that involved all markers on the same chromosome were considered separately since the mechanism underlying such LOH is likely to be different from that leading to LOH of only some markers on a given chromosome. Interestingly, 9p deletions were significantly associated with a higher FAL index, while 12p deletions were not correlated with the FAL. In a similar analysis, the FAL value was significantly higher in patients with structural chromosomal abnormalities detected by cytogenetics than in other patients (Table 3) .
Discussion
In a search for the localization of TSG we performed a high resolution allelotype analysis of 63 childhood ALLs using 247 fluorescent-labeled microsatellite markers. Forty patients (63%) had LOH for at least one marker while 23 patients had no LOH. The proportion of patients with LOH was higher than that detected in our previous study (45%) using only 46 markers 13 and similar to the allelotype reported by Takeuchi et al.
14 This latter study used 101 markers, some of which were chosen in regions known to be frequently deleted according to cytogenetic reports. The mean FAL value found in the present study is much lower than those reported for many solid tumor types that usually ranged from 0.20 to 0.35. 10, [17] [18] [19] [20] However, the FAL values reported for childhood ALLs here and in previous studies (0.03-0.123) are similar to the mean FAL (0.098) recently reported in CML blast crisis. 21 Among 63 patients who displayed 67 chromosomal regions with LOH, only 13 structural 
Figure 2
Pattern of LOH on 5p, 10p and 20q. í, LOH; , retention of heterozygosity;`, homozygosity.
abnormalities were indicated by the karyotype: five translocations (patients 3, 8, 15, 37, 39) and eight deletions (patients 19, 15, 26, 33, 41, 46, 48, 63) . On the other hand, in six cases, a deletion was detected by conventional cytogenetics, while LOH was not found in the corresponding region. Similar differences between the results of LOH studies and cytogenetics have already been reported. 13, 22 Three major factors may account for such differences: mechanisms other than deletion such as mitotic recombination or acquired parental unidisomy also result in LOH, small deletions may be undetected by conventional cytogenetics and some genomic alterations may be either positively or negatively selected during the culture step required for conventional cytogenetic analysis.
The observation that several patients who had LOH of all markers on one or several chromosomes in the absence of monosomy also had a hyperdiploid karyotype suggests that in these cases uniparental disomy may result from loss of one chromosome from a trisomy. Indeed clonal variations have been observed in hyperploid karyotypes 23 of childhood ALLs, implying a certain degree of chromosomal instability. Recent studies on colon adenocarcinoma cell lines found a very high degree of karyotypic instability with loss and gain of chromosomes occurring in many mitoses. 24 Such a high degree of chromosomal instability may partly account for the high FAL values found in allelotypes of many solid tumors but is not involved in childhood ALL. Indeed, a majority of children with a hyperdiploid karyotype do not show whole chromosome LOH. In this context, acquired uniparental disomy, as well as deletions, may mainly be observed as the result of a clonal expansion of cells and therefore may indicate the functional loss of a TSG.
A higher FAL index was found in patients with translocations and deletions than in other patients, though in most cases LOHs were detected at chromosomal loci different from those involving structural abnormality. This may reflect a dysregulation at recombination mechanism leading to both translocations and deletions in a subset of patients, possibly involving the V(D)J recombination system. 25 This subset of patients might be more prone to 9p deletions, as this abnormality, in contrast to 12p deletions, also correlates with a high FAL index.
The efficiency of allelotyping at the marker density we used in the present study (an average marker spacing of 10 megabases) depends on the average size of the deletions. Taking into account the informativeness of the markers, it can be estimated that the probability of detecting a 10 Mb deletion is approximately 0.7 and that this probability is inversely correlated with the size of the deletion. For chromosomal arms 9p and 12p, we also assessed LOH using markers situated in the proximity of target genes, respectively MTS1 and ETV6 (Refs 6, 26 and data not shown). The percentage of patients showing alterations of these loci that were in fact detected by the allelotyping were 60% and 74%, respectively.
The relevance of the observed LOH to leukemogenesis remains to be established. It is quite possible that some random LOH may reflect the clonal nature of the blast cells rather than contribute to the malignant phenotype. However, the recurrence of LOH in a few chromosomal regions suggests that they may participate in the sequential inactivation of the two TSG alleles. It is noteworthy that among the six most often deleted regions found in the present study, three regions were already known to be the target of frequent deletions (9p, 12p, 6q), the target genes being identified for two of them (9p and 12p). This rather encourages continuation of the search for the target gene in the other regions. It may be of interest that the region identified on the 20q chromosomal arm overlaps with a frequently deleted region in acute myelogenous leukemia, 27 as well as in myeloproliferative disorders. 28, 29 A more precise mapping of candidate regions found in this allelotype will be required before a positional cloning effort can be undertaken. A better delineation of the regions of interest will also help to find additional patients with smaller deletions than those identified using a relatively large spacing of the markers. This will permit a better estimation of the real prevalence of deletions in childhood ALLs. Distribution of the number of chromosomal regions displaying LOH. The distribution of the number of chromosomal regions displaying LOH for one or several contigous markers is indicated. Chromosomes with LOH for all markers were not included in this representation. 
